中文

美农生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥0.16B+59.3%
Gross profit¥0.05B
Operating income¥0.01B
Net income¥0.01B+51.4%
Gross margin31.5%Net margin 8.5%
Revenue Q/Q-7.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.11B68.5%
R&D¥0.01B3.3%
SG&A¥0.02B13.6%
Tax & other¥0.00B0.6%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

华塑科技德石股份三维天地翔楼新材唯万密封国能日新宏德股份优宁维建研设计通灵股份零点有数锡南科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies